Cardinal Health Stock Sees IBD RS Rating Improve To 71

By Investor's Business Daily   |   2 years ago
Cardinal Health Stock Sees IBD RS Rating Improve To 71

The RS Rating tracks market leadership by comparing a stock's price movement in the last 52 weeks with others in the database. Cardinal Health stock's rebound potential is linked to its RS Rating surpassing 80, making it a potential buy in a flat base.

Read More

Did you find this insightful?